NEW YORK (GenomeWeb) – Tempus and the University of Michigan's Comprehensive Cancer Center have announced a collaboration aimed at identifying the most effective care for breast cancer patients by analyzing molecular data related to in vitro biological models.

"While progress has been made in the battle against breast cancer, there are still too many unknowns that put the lives of those diagnosed at risk," Tempus Cofounder and CEO Eric Lefkofsky said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.